Skip to main content

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 PM Eastern Time (11:05 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

Contacts

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.40
+0.02 (0.01%)
AAPL  274.60
+0.79 (0.29%)
AMD  215.67
+0.63 (0.29%)
BAC  56.13
-0.12 (-0.20%)
GOOG  315.19
-0.48 (-0.15%)
META  663.92
-3.63 (-0.54%)
MSFT  487.08
-0.94 (-0.19%)
NVDA  190.89
+2.28 (1.21%)
ORCL  198.16
+0.67 (0.34%)
TSLA  478.50
-6.90 (-1.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.